Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study
AstraZeneca
Melissa L Johnson; Byoung Chul Cho; Alexander Luft; Jorge Alatorre-Alexander; Sarayut Lucien Geater; Konstantin Laktionov; Sang-We Kim; Grygorii Ursol; Maen Hussein; Farah Louise Lim; Cheng-Ta Yang; Luiz Henrique Araujo; Haruhiro Saito; Niels Reinmuth; Xiaojin Shi; Lynne Poole; Solange Peters; Edward B Garon; Tony Mok; POSEIDON investigators